Inogen Inc (INGN)
7.07
+0.13
(+1.87%)
USD |
NASDAQ |
Apr 18, 16:00
7.07
0.00 (0.00%)
After-Hours: 20:00
Inogen Cash from Investing (TTM): -59.32M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -59.32M |
September 30, 2023 | -70.39M |
June 30, 2023 | -29.35M |
March 31, 2023 | -23.94M |
December 31, 2022 | -10.88M |
September 30, 2022 | -16.31M |
June 30, 2022 | -10.40M |
March 31, 2022 | -19.68M |
December 31, 2021 | -14.64M |
September 30, 2021 | -20.79M |
June 30, 2021 | -29.91M |
March 31, 2021 | -33.55M |
December 31, 2020 | -25.64M |
September 30, 2020 | 24.33M |
June 30, 2020 | -41.37M |
March 31, 2020 | -28.21M |
December 31, 2019 | -44.06M |
September 30, 2019 | -73.51M |
June 30, 2019 | -9.351M |
March 31, 2019 | -25.92M |
December 31, 2018 | -24.96M |
Date | Value |
---|---|
September 30, 2018 | -30.01M |
June 30, 2018 | -26.32M |
March 31, 2018 | -26.65M |
December 31, 2017 | -24.43M |
September 30, 2017 | -21.94M |
June 30, 2017 | -26.80M |
March 31, 2017 | -16.63M |
December 31, 2016 | -11.93M |
September 30, 2016 | -11.85M |
June 30, 2016 | -7.982M |
March 31, 2016 | -24.32M |
December 31, 2015 | -29.30M |
September 30, 2015 | -33.71M |
June 30, 2015 | -30.73M |
March 31, 2015 | -17.07M |
December 31, 2014 | -16.25M |
September 30, 2014 | -15.02M |
June 30, 2014 | -16.57M |
March 31, 2014 | -17.80M |
December 31, 2013 | -18.14M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-73.51M
Minimum
Sep 2019
24.33M
Maximum
Sep 2020
-28.26M
Average
-25.64M
Median
Dec 2020
Cash from Investing (TTM) Benchmarks
Oragenics Inc | -0.9363M |
Palatin Technologies Inc | 9.293M |
Oramed Pharmaceuticals Inc | -73.04M |
vTv Therapeutics Inc | -- |
G1 Therapeutics Inc | 2.81M |